LXRX
Lexicon Pharmaceuticals Inc
1.70$
-4.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -342.8% | – | – | – | – | – | – | – | – | – | -195.0% | – | – | – | -225.6% | – | – | – | – | – | |
| – | +31.0% | +531.4% | +24.3% | +4.6% | -40.2% | -9.6% | -3.7% | -7.0% | -3.4% | -38.8% | -12.4% | -9.4% | -14.3% | -31.7% | -32.7% | -62.3% | +182.8% | +65.3% | +8.4% | -0.8% | -19.7% | -90.0% | +46.2% | +29.7% | -3.6% | +16.3% | |
| – | – | – | – | – | – | – | – | +12.7% | -18.0% | -18.9% | +3.9% | +4.2% | +13.8% | +14.3% | -4.6% | -3.4% | +8.9% | +27.1% | +23.5% | +21.6% | -6.6% | -20.3% | +8.9% | +24.5% | -5.9% | -7.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +24.3% | -68.2% | +290.6% | -19.8% | -58.5% | -116.0% | – | -29.9% | +53.2% | -15.4% | +8.4% | – | – | – | |
| – | +14.5% | -38.7% | +1,498.4% | +215.7% | -124.9% | – | -143.4% | – | – | – | – | +913.2% | -147.2% | – | -53.9% | +7,399.6% | -125.3% | – | – | – | – | -132.9% | – | +561.4% | +435.5% | -288.9% | |
| – | +88.0% | +74.7% | +46.7% | -75.6% | +144.8% | -4.5% | -68.3% | -46.9% | +15.1% | -83.1% | +206.8% | +6.5% | -59.2% | +249.8% | -95.4% | +1,037.5% | -74.6% | -1.3% | -58.3% | -26.3% | +24.3% | +1,303.4% | +8.6% | -64.6% | +119.4% | -100.0% | |
| – | -3,281.7% | – | +635.8% | -100.3% | – | -139.5% | – | -868.2% | – | -92.5% | -1,058.5% | – | -239.8% | – | -208.9% | +7.9% | – | +176.8% | +235.6% | -191.9% | – | -99.4% | -3,468.6% | -29.7% | -69.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -59.8% | -100.0% | – | – | – | -100.0% | – | – | – | -94.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +69.3% | -27.5% | +163.9% | +206.3% | +1.6% | -59.8% | +73.9% | +170.4% | -42.1% | -3.2% | +9.0% | +160.7% | -67.7% | -4.6% | +110.0% | -66.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -59.8% | +9.1% | – | -102.3% | +8.4% | – | -101.4% | -35.9% | +16,754.5% | -94.6% | – | +2.2% | -100.0% | – | |
| – | +5,862.8% | -101.6% | – | +1,001.8% | -138.6% | -99.5% | – | +526.5% | -100.3% | – | +55.6% | +10.0% | -76.8% | -103.8% | – | -100.7% | – | +15,090.8% | -101.5% | -0.8% | +6,532.3% | – | +526.2% | +32.2% | +26.8% | -120.3% | |
| – | – | -141.3% | – | +85.0% | -149.9% | – | +12.2% | -188.3% | – | -76.7% | -463.4% | – | -212.1% | – | +1,309.9% | -34.1% | -338.0% | – | +24.3% | -336.4% | – | -169.0% | – | – | – | -107.5% | |
| – | – | – | – | – | – | – | -597.4% | – | – | – | – | – | – | – | – | – | -195.6% | – | – | – | -225.8% | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.